Skip to main content
SpringerLink
Log in

Glioblastoma

Histone mutations take the MYCN

  • Research Highlight
  • Published:

From Nature Reviews Cancer

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

ORIGINAL RESEARCH PAPER

  1. Bjerke, L. et al. Histone H3.3 mutations drive pediatric glioblastoma through upregulation of MYCN. Cancer Discov. 28 Mar 2013 (doi:10.1158/2159-8290.CD-12-0426)

    Article  CAS  Google Scholar 

FUTHER READING

  1. Lewis, P. W. et al. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 28 Mar 2013 (doi:10.1026/science.1232245)

  2. McCarthy, N. The histones have it. Nature Rev. Cancer 8 Apr 2013 (doi:10.1038/nrc3517)

    PubMed  Google Scholar 

Download references

Authors
  1. Nicola McCarthy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McCarthy, N. Histone mutations take the MYCN. Nat Rev Cancer 13, 382–383 (2013). https://doi.org/10.1038/nrc3527

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrc3527

  • Springer Nature Limited

Search

Navigation